About
Male
Philip Breitfeld is the current Chief Medical Officer of Radiomer Therapeutics. He previously worked at IQVIA as a Vice President and Global Head of Therapeutic Centers of Excellence. Philip Breitfeld attended Princeton University.
Experience
Champions Oncology
View →Chief Strategy and Innovation Officer
IPO182Hackensack, New Jersey, United StatesBiotech/Pharma · Biotechnology
- CMO · Radiomer Therapeutics2024 – present
- Member · MMS Holdings Inc.2023 – present
- Chief Medical Officer · Allterum Therapeutics2020 – present
Education
- Indiana University School of Medicine · Medical Informatics1997 – 1999
- Harvard Medical School · Fellowship, Pediatric Hematology/Oncology1982 – 1985
- University of Rochester School of Medicine and Dentistry · MD, Medicine1975 – 1979
- Princeton University · A.B., Chemistry1971 – 1975
People at Champions Oncology
Data from: crunchbase
